Uncategorized

Uncategorized

New Releases from NCBI BookshelfCrovalimab (Piasky): Indication: For the treatment of paroxysmal nocturnal hemoglobinuria (PNH) in adults and adolescents 13 years of age and older with a body weight of at least 40 kg: Reimbursement Recommendation [Internet].​Crovalimab (Piasky): Indication: For the treatment of paroxysmal nocturnal hemoglobinuria (PNH) in adults and adolescents 13 years of age and older with a body weight of at least 40 kg: Reimbursement Recommendation [Internet].

Canada’s Drug Agency (CDA-AMC) recommends that Piasky be reimbursed by public drug plans for the treatment of patients with paroxysmal

Uncategorized

New Releases from NCBI BookshelfDoes a Community Education Program Help Increase Early Hospital Arrival and Ambulance Use for Patients Who Experience Stroke?—The CEERIAS Study [Internet].​Does a Community Education Program Help Increase Early Hospital Arrival and Ambulance Use for Patients Who Experience Stroke?—The CEERIAS Study [Internet].

Early hospital arrival after stroke onset increases access to proven treatments and improves outcomes. In addition to knowledge and recognition

Uncategorized

New Releases from NCBI BookshelfUsing Research Networks to Compare Medicines for Autoimmune and Inflammatory Diseases – The Comparative Health Outcomes in Immune-mediated diseases CollaborativE (CHOICE) Study [Internet].​Using Research Networks to Compare Medicines for Autoimmune and Inflammatory Diseases – The Comparative Health Outcomes in Immune-mediated diseases CollaborativE (CHOICE) Study [Internet].

Individuals with autoimmune and inflammatory diseases who seek treatment face a rapidly changing and confusing landscape that includes multiple immunosuppressive

Scroll to Top